RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.
about
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseasesHSV-1 tegument protein and the development of its genome editing technologyCRISPR/Cas9 and cancer targets: future possibilities and present challengesEnabling functional genomics with genome engineeringAdvances in CRISPR-Cas9 genome engineering: lessons learned from RNA interferenceEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus ResistanceBacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentCRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent InfectionsCRISPR/Cas9-mediated viral interference in plantsInhibition of HSV-1 Replication by Gene Editing StrategyGenome editing and the next generation of antiviral therapy.Applications of CRISPR technologies in research and beyond.Genome editing strategies: potential tools for eradicating HIV-1/AIDS.Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs.The CRISPR/Cas9 genome editing methodology as a weapon against human virusesCRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC InfectionCRISPR/Cas9-The ultimate weapon to battle infectious diseases?Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeuticDetection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9Transgenic Clustered Regularly Interspaced Short Palindromic Repeat/Cas9-Mediated Viral Gene Targeting for Antiviral Therapy of Bombyx mori Nucleopolyhedrovirus.CRISPR-Cas9: a new and promising player in gene therapy.CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.CRISPR Editing in Biological and Biomedical Investigation.A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joiningCRISPR-Cas9 technology and its application in haematological disorders.Epigenetics and Genetics of Viral Latency.The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.CRISPR/Cas9: at the cutting edge of hepatology.Type II CRISPR/Cas9 approach in the oncological therapy.Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication.The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System.Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system.
P2860
Q26744172-50EDC0D7-3A6C-4C5B-989C-0B8E79C21EABQ26747146-769038A1-7C30-475D-800A-3A55B014D9AEQ26769907-D9FDD848-98DE-4220-BA95-BE1A08744084Q26782747-F29B45CB-46F7-4BEC-8414-771E2BF18D84Q26852489-0C8B09C9-EDDA-4ED3-88E0-C3F26771EA20Q26861350-758D68BD-2005-490C-A8DB-FFBCCBB88134Q28074250-574F854C-3EFF-4B88-AA90-7F1220E9F7ABQ28087526-F533022A-9D3F-4C75-A3D5-88DE34715709Q28552274-FF05E21A-3DCA-4247-92C6-E0D02400E45FQ34045362-DCF20172-60EC-4D11-B13C-8DA75EAFC12FQ34521509-EA3F4796-ECE1-4688-868E-55BED8F10637Q34529971-2F4BF915-982A-493B-A434-E85DE789F8EFQ34539796-2EFE08E6-51AF-4E96-8AD7-F3E26132E39CQ35612053-B1D09498-8D81-4559-9A3A-F4FECEB86E82Q35650064-296556E5-511F-4FDE-B4A1-09B44039506CQ35654689-58166AA6-C1DD-498E-9964-8923380B9B70Q35770584-BABDB804-AF9D-4D6C-8381-FEA7B2241679Q36196813-A0D8AD63-32BE-4A18-A9AA-D57372E77A6BQ36216276-BF003002-2F74-428D-85F5-6F68BFC98B55Q36386251-89224CB1-E2CC-41D0-B7EC-A77D644C73F9Q36494284-D121C65D-3AE0-4033-A7EA-5481ED478C4AQ36650962-0EB4B5A1-C35F-4E2D-A76F-9BC8DF9D3A35Q36730743-172DC9DC-0817-4BFC-B9EF-DC176916CC4BQ36812001-46543118-22FA-46C7-AF73-8C5A993D4CD7Q37411994-12A7C6C3-F55C-4F01-BD38-0F7CD8C7E2D0Q37732408-A475250F-435B-46FF-89AB-AD7C89A98795Q38364993-6A13BB86-137E-480B-9C27-4F5DDC1B56B3Q38516454-1C16C132-A564-4F49-9023-6C310CC4EA78Q38645581-63185377-E775-4429-9BE1-A21F3032AA39Q38759997-9A5EBA0B-CF5C-44DD-9E05-0C1E483A5D47Q38804017-06B60CDE-5F33-4836-961D-7BD9E5BDA2CAQ38822073-79A7404E-117F-48EA-8434-DCE4E0B5749DQ38833222-7C8DBA34-BDEE-4FCF-B974-F014C778588FQ39260698-9A34316E-3FF7-49CF-8DCC-D2B913B3AF03Q39294371-0EE15BC2-5BCD-477F-99D9-A76A7D22FB01Q39376221-8CA55F03-A28F-4843-B548-0747EFB794FCQ40040519-8FDAFE5B-CB5F-44F1-A06B-F598517A2B8BQ40044279-397427D1-2790-4E50-9854-FB4E84CFB0CFQ41035560-B1758E59-33C0-40D0-8C81-C846889858E3Q41930897-5B54A65F-ACCE-4C2E-A544-F614565D1548
P2860
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@ast
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@en
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@nl
type
label
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@ast
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@en
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@nl
prefLabel
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@ast
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@en
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@nl
P2860
P356
P1476
RNA-guided endonuclease provid ...... atent herpesviridae infection.
@en
P2093
Jianbin Wang
Stephen R Quake
P2860
P304
13157-13162
P356
10.1073/PNAS.1410785111
P407
P577
2014-08-25T00:00:00Z